Download Publications avant 2010

Publications de Patrick BARIL
,
Merron A, Baril P, Martin-Duque P, De La Vieja A, Tran L, Briat A, Harrington KJ, Mc Neish IA Vassaux G.
Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in
peritoneal tumors. Eur. J. Nucl. Med. Mol. Imaging 2009, In Press (Illustration de la Revue)
*Peerlinck I, *Merron A, *Baril P, Conchon S, Martin-Duque P, Hindorf C, Burnet J, Quintanilla M, Hingorani
M, Iggo R, Lemoine N, Harrington K, Vassaux G. Targeted radionuclide therapy using a wnt-targeted
*
replicating adenovirus encoding the Na/I symporter. Clin Cancer Res., 2009, 15(21) : 6595-601. Cofirst auteur
Dai MS, Nitcheu-Tefit J, Alcock S, Ramirez-Jimenez F, Chao TY, Baril P, Rocha M, Brett SJ, Stauss HJ,
Vassaux G. Development of an escherichia coli expressing listeriolysin-o vaccine against Wilms’ tumor
gene 1-expressing tumors. J. Immunother., 2009, 32(8):845-855
Baril P, Martin-Duque M, Vassaux G. Visualisation of gene expression in the live subject using the Na/I
symporter as a reporter gene : applications in biotherapy. Br. J. Pharmacol., 2009, In Press
Chisholm EJ, Vassaux G, Martin-Duque P, Chevre R, Lambert O, Pitard B, Merron A, Weeks M, Burnet J,
Peerlinck I, Dai MS, Mather SJ, Bolton K, Uchegbu IF, Schatzlein AG, Baril P. Cancer-specific
transgene expression mediated by systemic injection of nanoparticles. Cancer Res., 2009 69(6) : 26552662
,
Belmar-Lopez P. Mancheno-Corvo T, Saornil MA, Baril P, Vassaux G, Quintanilla M, Martin-Duque P. Uveal
vs cutaneous melanoma : origins and causes of the differences. Clin. Transl. Oncol., 2008 10(3) : 137142
Harada T, Chelala C, Bhakta V, Chaplin T, Caulee K, Baril P, Young BD, Lemoine NR. Genome-wide DNA
copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays.
Oncogene, 2007, 27(13) : 1951-1960
Mahon PC*, Baril P*, Bhakta V, Chelala C, Caulee K, Harada T, Lemoine NR. S100A4 contributes to the
suppression of BNIP3 expression and to the chemoresistance of pancreatic cancer cells to gemcitabine.
*
Cancer Res., 2007; 67(14) :6786-6795. Co-first auteur
Tomohiko H, Baril P, Mahon PC, Bhakta V, Caulee K, Crnogorac-Jurcevic T, Lemoine NR. Tumour-specific
genetic alterations in pancreatic cancer detected by array-based comparative genomic hybridisation. Br.
J. Cancer, 2007, 96(2):373-382
Baril P, Gangeswaran R, Mahon PC, Krishna C, Kocher H, Holger K, Crnogorac-Jurcevic T, Lemoine NR.
Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death:
role of the β4 integrin and the PI3k pathway. Oncogene, 2007, 26(14) : 2082-2094.
Boukerche H, Suzz, Emdad L, Baril P, Balme B, Thomas L, Randolph A, Valerie K, Fisher PB. MDA-9/syntenin:
a positive regulator of melanoma metastasis. Cancer Res., 2005; 65 (23) :10901-10911.
Baril P, Nejjari M, Scoazek Jy, Boukerche H. Blocking a novel 55 kda. Melanoma-associated cell surface
antigen inhibits the development of spontaneous metastases and interactions with frozen lung section.
Int. J. Cancer, 2002, 99 (3) : 315-322 (Illustration de la revue)
Belaiba RS, Baril P, Chebloune Y, Tabone E, Boukerche H. Identification and cloning of an 85 kda. Protein
homologous to ring3 that is upregulated in proliferating endothelial cells. Eur. J. Biochem., 2001, 268
(16) : 4398-43407
Boukerche H*, Baril P*, Tabone E, Berard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L. A new Mr
55,000 surface protein implicated in melanoma progression : association with a metastatic phenotype.
*
Cancer Res., 2000, 60 (20) : 5848-5856 . Co-first auteur
Scientific congress
- Baril P, Vassaux G. Visualization of gene expression in the live subject using the Na/I symporter as gene
reporter : application in biotherapy. Invited Oral Communication « Moderm Biological Imaging needs
biophysics » The Polish French School, Faculty of Biochemistry Biophysic and biotechnology,
th
th
Jagellionan University of Krakow, Poland February 17 -20 2010
- Chisholm EJ, Vassaux G, Chevre R, Lambert O, Pitard B, Mather Sj, Schatzlein AG and Baril P . Cancerspecific targeting and imaging upon the systemic injectionin mice of dendrimer nanoparticles complexed
to dna plasmids encoding the sympoter Na/I (NIS) as gene reporter. Oral Communication at “Third
Berder Meeting : Targeting And Imaging Of Tumour Microenvironment” Berder Island, Morbihan, France
th
th
September 13 -26 2009
- Baril P, Mahon PC, Gangeswaran R, Caulee K, Kocher HR, Crnogorac-Jurcevic T, Lemoine NR. Periostin
promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of
the β4 integrin and the PI3k pathway. Late Breaking Poster at «2006 AACR Annual Meeting»
Washington DC, USA, 2006, April 1-5. Abstract Number LB-163
- Mahon PC, Baril P, Lattimore S, Caulee K, Lemoine NR. S100a4 contributes to the suppression of BNIP3
expression in pancreatic cancer. Late Breaking Poster at «2006 AACR Annual Meeting» Washington
DC, USA, 2006, April 1-5. Abstract Number LB-123
- Baril P, Gangeswaran R, Mahon PC, Crnogorac-Jurcevic T Lemoine NR. A role of periostin in pancreatic
cancer : implication of the 4 integrin and the PI3 kinase cell signalling pathway. Poster at « Gene &
nd
Cancer 2005 – 22 Meeting » University Of Warwick, Uk, 2005, 12-14 December 2005. Abstract
Number A8
- Baril P and Boukerche H. Identification d’une nouvelle molécule de surface (55 Kda.) impliquée dans la
progression tumorale du mélanome humain. Oral Communication at « Xxème Forum De Cancérologie,
Eurocancer 2000». Paris, France, 2000, 6-8 June
- Boukerche H, Baril P, Bel Aiba Rs, Mcgregor JL. Identification of a new surface protein (55 kda.) implicated
in melanoma tumor progression : generation of a monoclonal antibody (LYP23) through substractive
th
immunization. Oral Communication at « XVII congress of the international society on thrombosis and
haemostasis » Washington Dc, Usa, 1999, August 14-21. Thrombosis And Haemostasis, 1999, 46 : 16
(Abstract)
- Baril P, Bel Aiba RS, Mcgregor JL, and Boukerche H. Characterization of a new monoclonal antibody
(LYP23) directed against a 55 kda. surface protein that inhibits melanoma interactions with frozen lung
th
sections. Poster at « XVII congress of the international society on thrombosis and haemostasis »
Washington DC, USA, 1999, August 14-21. Thrombosis And Haemostasis, 1999, 1089 : 344 (Abstract)